Securities code: 688607 securities abbreviation: Careray Digital Medical Technology Co.Ltd(688607) Announcement No.: 2022-008 Careray Digital Medical Technology Co.Ltd(688607)
Self inspection report on the trading of company shares by insiders and incentive objects of the restricted stock incentive plan in 2022
The board of directors shall not be liable for any misrepresentation, omission or material misrepresentation of the contents of this announcement, and shall not guarantee the truthfulness and completeness of the contents of this announcement.
Careray Digital Medical Technology Co.Ltd(688607) (hereinafter referred to as “the company”) held the fifth (Interim) meeting of the second board of directors and the fifth (Interim) meeting of the second board of supervisors respectively on January 20, 2022, deliberated and adopted the proposal on the company’s restricted stock incentive plan in 2022 (Draft) > and summary and other relevant proposals, It is proposed to implement the restricted stock incentive plan in 2022 (hereinafter referred to as the “incentive plan”), and the specific contents are detailed in the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 21, 2022 Relevant announcements disclosed on.
According to the relevant provisions of the measures for the administration of equity incentive of listed companies, Through China Securities Depository and Clearing Co., Ltd. Shanghai Branch, the company conducted a self inspection on the purchase and sale of the company’s shares by insiders and incentive objects of the incentive plan within 6 months before the announcement of the incentive plan (Draft) (i.e. from July 20, 2021 to January 20, 2022, hereinafter referred to as the “self inspection period”). The details are as follows:
1、 Scope and procedure of verification
1. The verification objects include insiders of the incentive plan and incentive objects.
2. The insiders of the incentive plan have filled in the registration form of insiders.
3. The company applied to China Securities Depository and Clearing Co., Ltd. Shanghai branch to inquire about the purchase and sale of the company’s shares by the verification object during the self inspection period. China Securities Depository and Clearing Co., Ltd. Shanghai Branch has issued the inquiry certificate of shareholding and share change of information disclosure obligor and the detailed list of shareholder share change. 2、 Description of the purchase and sale of the company’s shares by the verification object
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued by China Securities Depository and Clearing Co., Ltd. Shanghai Branch, during the self-examination, except for the verification objects listed in the table below, the other verification objects did not buy or sell the company’s shares.
Summary of change of name during trading period total number of changed shares (shares)
Purchase 1300 from July 30, 2021 to December 23, 2021
Xu Yong
1300 sold from August 5, 2021 to December 24, 2021
Buy 4365 from July 22, 2021 to January 20, 2022
Zhu Yuehua
From August 10, 2021 to August 25, 2021, 2300 sales
Purchase 1600 from October 22, 2021 to October 25, 2021
Jian Chen
1600 sold on November 10, 2021
Buy 1251 from September 14, 2021 to October 28, 2021
Qiao peipeng
Sold 1251 from October 11, 2021 to January 10, 2022
2021 / 08 / 03-2021 / 08 / 04 buy 500
Xie Qingkun
Sold 1600 from July 22, 2021 to December 27, 2021
Buy 200 on July 26, 2021
Wang Yuanzhe
200 sold on August 5, 2021
Yin Yanshu buys 500 shares on July 27, 2021
Cheng Jia buys 400 from July 27, 2021 to December 21, 2021
Buy 46198 from August 23, 2021 to January 17, 2022
Lu Jiyun
From August 25, 2021 to January 18, 2022, 46198 sold
The trading changes of the above verification objects during the self inspection period are the operation based on their own judgment on the trading situation of the secondary market and personal capital arrangement. During the self inspection period, they did not obtain the relevant information of the company’s plan to implement the incentive plan from the insider of the incentive plan, and there is no insider trading.
In the process of planning this incentive plan, the company strictly follows the measures for the administration of information disclosure of listed companies, the guidelines for the supervision of listed companies No. 5 – registration and management system for insiders of listed companies and relevant internal confidentiality systems of the company, limits the scope of personnel participating in the planning and discussion, and takes corresponding confidentiality measures. The company has registered insiders who have participated in the stages of negotiation and planning, demonstration and consultation, decision-making and discussion of the incentive plan. The insider information is strictly controlled within the scope of the personnel registered in the insider registration form. Before the company discloses the relevant announcements of the incentive plan, no disclosure of insider information is found.
3、 Concluding observations
To sum up, during the self-examination, the company did not find any disclosure of inside information, nor did it find that the insiders and incentive objects of the incentive plan used the relevant inside information of the incentive plan to buy and sell the company’s shares.
It is hereby announced.
Careray Digital Medical Technology Co.Ltd(688607) board of directors February 12, 2022
